Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?

Streptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed c...

Full description

Saved in:
Bibliographic Details
Main Authors: U. R. Goonetilleke, S. A. Ward, S. B. Gordon
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Interdisciplinary Perspectives on Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2009/214216
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559339305435136
author U. R. Goonetilleke
S. A. Ward
S. B. Gordon
author_facet U. R. Goonetilleke
S. A. Ward
S. B. Gordon
author_sort U. R. Goonetilleke
collection DOAJ
description Streptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed countries, approximately half of the survivors suffer intellectual impairment, hearing loss, or other neurological damage. There is an urgent need for more information about the mechanisms of brain damage and death in pneumococcal meningitis so that new treatments can be designed. Using proteomic techniques and bioinformatics, the protein content of cerebrospinal fluid can be examined in great detail. Animal models have added greatly to our knowledge of possible mechanisms and shown that hippocampal apoptosis and cortical necrosis are distinct mechanisms of neuronal death. The contribution of these pathways to human disease is unknown. Using proteomic techniques, neuronal death pathways could be described in CSF samples. This information could lead to the design of novel therapies to minimize brain damage and lower mortality. This minireview will summarize the known pathogenesis of meningitis, and current gaps in knowledge, that could be filled by proteomic analysis.
format Article
id doaj-art-347b9b225b9d4e7d9727992b3b44df4c
institution Kabale University
issn 1687-708X
1687-7098
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Interdisciplinary Perspectives on Infectious Diseases
spelling doaj-art-347b9b225b9d4e7d9727992b3b44df4c2025-02-03T01:30:14ZengWileyInterdisciplinary Perspectives on Infectious Diseases1687-708X1687-70982009-01-01200910.1155/2009/214216214216Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?U. R. Goonetilleke0S. A. Ward1S. B. Gordon2Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKMolecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKPulmonary Immunology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKStreptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed countries, approximately half of the survivors suffer intellectual impairment, hearing loss, or other neurological damage. There is an urgent need for more information about the mechanisms of brain damage and death in pneumococcal meningitis so that new treatments can be designed. Using proteomic techniques and bioinformatics, the protein content of cerebrospinal fluid can be examined in great detail. Animal models have added greatly to our knowledge of possible mechanisms and shown that hippocampal apoptosis and cortical necrosis are distinct mechanisms of neuronal death. The contribution of these pathways to human disease is unknown. Using proteomic techniques, neuronal death pathways could be described in CSF samples. This information could lead to the design of novel therapies to minimize brain damage and lower mortality. This minireview will summarize the known pathogenesis of meningitis, and current gaps in knowledge, that could be filled by proteomic analysis.http://dx.doi.org/10.1155/2009/214216
spellingShingle U. R. Goonetilleke
S. A. Ward
S. B. Gordon
Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
Interdisciplinary Perspectives on Infectious Diseases
title Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
title_full Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
title_fullStr Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
title_full_unstemmed Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
title_short Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
title_sort could proteomic research deliver the next generation of treatments for pneumococcal meningitis
url http://dx.doi.org/10.1155/2009/214216
work_keys_str_mv AT urgoonetilleke couldproteomicresearchdeliverthenextgenerationoftreatmentsforpneumococcalmeningitis
AT saward couldproteomicresearchdeliverthenextgenerationoftreatmentsforpneumococcalmeningitis
AT sbgordon couldproteomicresearchdeliverthenextgenerationoftreatmentsforpneumococcalmeningitis